Secondary prevention of stroke: Old and new evidence

Aging Clinical and Experimental Research

Volumn 14, Issue 3, 2002, Pages 216-220

  Mancia, Giuseppe ^a   Grassi, Guido ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

Blood pressure; Blood pressure lowering drugs; Elderly; Prevention of stroke; PROGRESS study; Recurrent stroke

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDAPAMIDE; PERINDOPRIL; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; RISK FACTOR; SECONDARY PREVENTION; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 0036623822     PISSN: 03949532     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03324440     Document Type: Article

References (26)

1. World Health Organization. The World Health Report 1999, 1999.
2. Bonita R. Epidemiology of stroke. Lancet 1992; 339: 342-4.
3. Hankey G, Warlow C. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet 1999; 354: 1457-63.
4. UK-TIA Study Group. The United Kingdom transient ischemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991; 54: 1044-54.
5. Antiplatelet Trialist Collaboration. Collaborative overview of randomized trials of antiplatelet therapy - Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106.
6. Algra A, Van Gijn J. Cumulative meta-analysis of aspirin efficacy after cerebral ischemia of arterial origin. J Neurol Neurosurg Psychiatry 1999; 66: 255.
7. Hart R, Benavente O, McBride R, Pearce L. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999; 131: 492-501.
8. Barnett H, Taylor D, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endoarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415-25.
9. Benavente O, Moher D, Pharm B. Carotid endarterectomy for asymptomatic carotid stenosis: a meta-analysis. BMJ 1998; 317: 1477-80.
10. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part I. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74.
11. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure and stroke: 13000 strokes in 450000 people in 45 prospective cohorts. Lancet 1995; 346: 1647-53.
12. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol and stroke in eastern Asia. Lancet 1998; 352: 1801-7.
13. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994; 50: 272-98.
14. Blood Pressure Lowering Treatment Trialist Collaboration. Effects of ACE inhibitors, calcium antagonists and other blood pressure lowering drugs: results of prospectively designed overviews of randomized trials. Lancet 2000; 356: 1955-64.
15. Rodgers A, MacMahon S, Gamble G, et al. Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischemic Attack Collaborative Group. BMJ 1996; 313: 147-53.
16. Rodgers A, Neal B, MacMahon S. The effects of blood pressure lowering in cerebrovascular disease. Neurol Rev Int 1997; 2: 12-5.
17. Gueyffier F, Boissel JP, Bouttle F, et al. Effect of antihypertensive treatment in patients having already suffered from stroke: gathering the evidence. Stroke 1997; 28: 2557-62.
18. Carter AB. Hypotensive therapy in stroke survivors. Lancet 1970; i: 485-9.
19. The Dutch TIA Trial Study Group. Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. Stroke 1993; 24: 543-8.
20. Hypertension Stroke Co-operative Study Group. Effect of antihypertensive treatment on stroke recurrence. JAMA 1974; 229: 409-18.
21. Gueyffier F, Froment A, Gouton N. New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit. J Hum Hypertens 1996; 10: 1-8.
22. Bosch J, Yusuf S, Pogue J, et al. Impact of ramipril and vitamin E on cerebrovascular events in the HOPE (Heart Prevention Evaluation) trial. J Am Coll Cardiol 2000; 35 (Suppl A): 324A.
23. PROGRESS Management Committee. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. J Hypertens 1999; 17: 1647-55.
24. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 2001; 358: 1033-41.
25. Staessen JA. Potential adverse effects of blood pressure lowering-J-curve revisited. Lancet 1996; 3: 217-22.
26. Ferrari AU, Grassi G, Mancia G. Alteration in reflex control of the circulation associated with aging. In Amery A, Staessen J, Eds. Handbook of Hypertension: Hypertension in the elderly. Amsterdam: Elsevier Publishers, Vol. 12, 1989: 39-50.